World Bio Markets 2017

Published: 6-May-2016

A global gathering of decision makers driving growth and innovation throughout the bioeconomy. WBM bridges the gaps across the biofuel value chain; linking feedstock to end user, via production and technology; showcases and builds a platform to grow upon the advances in the biobased chemical industry; and unearths the opportunities for biomass power development, navigating varying regulatory climates.

Organiser: GreenPower Conferences

www.worldbiomarkets.com

Trending Articles

  1. Cleanroom Conference UK 22–23 May 2024 | Exhibition | Birmingham, UK
  2. Making Pharmaceuticals 23–24 April 2024 | Exhibition | Coventry, UK
  3. Lounges 23-25 April 2024 | Conference | Messe Karlsruhe, Germany
  4. Interphex 16-18 April 2024 | Conference and Exhibition | New York, US
  5. KOREA CHEM 2023 18-21 April 2023 | Exhibition | Korea

You may also like

Manufacturing

CordenPharma & GENEPEP collaborate to leverage peptide drug substance discovery

The partnership has facilitated the expedition of the development, discovery and manufacturing of peptides for early clinical phase
Sustainability

Building strong foundations for a resilient and planet-friendly future

Having recently released its inaugural environmental, social and governance (ESG) report, Dr Kevin Robinson caught up with Gigi Bat-Erdene, Global ESG Program Manager at PCI Pharma Services, to find out how this leading CDMO is tackling climate science, workforce empowerment, responsible waste management and supply chain security
Sustainability

Dickson achieves ISO 14001 certification

ISO 14001 certification highlights a companies' long-term efforts to manage its environmental impact
Distribution

Envirotainer releases annual sustainability report

The sustainability report focuses on the long-term goals of the company, and what has been done to achieve them
Sustainability

Bespak separation from Recipharm to focus on the transition to low GWP pMDIs

The spin-out has created a global CDMO focused on drug-device combination products and drug delivery devices for pulmonary and nasal inhalation
Ingredients

Therapeutic: acoramidis for transthyretin amyloid cardiomyopathy

Transthyretin amyloid cardiomyopathy (ATTR-CM) is a rare progressive disease that results from genetic mutations or ageing; misfolded TTR protein accumulates as amyloid fibrils in the myocardium
Ingredients

Therapeutic: lutikizumab for hidradenitis suppurativa

Hidradenitis suppurativa (HS) — also known as acne inversa — is a chronic, recurrent and progressive inflammatory disease that leads to irreversible skin damage and disability
Subscribe now